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Effects of a Gluco-oligosaccharide on Growth Performance of Nursery Pigs 
Abstract 
A total of 3,456 nursery pigs (PIC L337 × 1050, initially 12.4 lb BW) were housed in 3 commercial research 
rooms and used in a 42-d growth study to determine the effects of gluco-oligosaccharide (Midori USA, 
Inc., Cambridge, MA) on growth performance. In each room, pens of pigs (27 pigs/pen) were blocked (6, 
5, and 5 blocks in rooms 1, 2, and 3, respectively) by initial pen BW. Within blocks, pens were allotted 
randomly to 1 of 8 dietary treatments in a 2-phase feeding program (d 0 to 14 and d 14 to 42). Dietary 
treatments were arranged in a 2 × 3 factorial, with or without antibiotic (0 or 55 ppm, Carbadox, Phibro 
Pro, Teaneck, NJ) and 4 concentrations of gluco-oligosaccharide (0, 200, 400, and 600 ppm). Gluco-
oligosaccharide product used in rooms 1 and 2 originated from a different batch than that used in room 3. 
For the overall feeding period, no room × antibiotic × gluco-oligosaccharide or antibiotic × 
glucooligosaccharide interactions were observed for any growth responses, but tendencies were found (P 
< 0.10) for room × gluco-oligosaccharide interaction for final BW and ADG. In rooms 1 and 2, antibiotic 
treatment increased ADG and ADFI in all feeding periods and improved F/G from d 14 to 28 and d 28 to 
42. Increasing gluco-oligosaccharide improved (linear, P < 0.05) ADG and F/G from d 0 to 14. It also 
increased (P = 0.047) ADG and tended (P = 0.087) to increase ADFI from d 14 to 28, but did not alter the 
growth responses from d 28 to 42. For the overall period (d 0 to 42), adding an antibiotic to the diet 
increased (P < 0.01) ADG and ADFI, but did not affect F/G. Increasing gluco-oligosaccharide improved 
(linear, P < 0.01) ADG and F/G and tended (P = 0.063) to linearly increase ADFI. In room 3, a much smaller 
response was observed for antibiotic inclusion with only improved (P = 0.005) F/G from d 14 to 28 and 
increased (P < 0.05) ADG and ADFI from d 28 to 42. Pigs fed increasing glucooligosaccharide tended 
(linear, P < 0.10) to have reduced ADG and ADFI; however, the overall growth performance was not 
affected by antibiotic or gluco-oligosaccharide treatments. In conclusion, feeding gluco-oligosaccharide 
may improve growth performance in nursery pigs, and this effect appears to be independent of the use of 
antibiotic and more prominent during the early nursery phase. However, due to some room × gluco-
oligosaccharide interactions, further research is required to confirm the consistency of the responses to 
the gluco-oligosaccharide used in this study. 
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Effects of a Gluco-oligosaccharide on 
Growth Performance of Nursery Pigs1
F. Wu, M.D. Tokach, J.M. DeRouchey, S.S. Dritz,2 J.C. Woodworth, and 
R.D. Goodband 
Summary
A total of 3,456 nursery pigs (PIC L337 × 1050, initially 12.4 lb BW) were housed in 
3 commercial research rooms and used in a 42-d growth study to determine the effects 
of gluco-oligosaccharide (Midori USA, Inc., Cambridge, MA) on growth performance. 
In each room, pens of pigs (27 pigs/pen) were blocked (6, 5, and 5 blocks in rooms 1, 
2, and 3, respectively) by initial pen BW. Within blocks, pens were allotted randomly 
to 1 of 8 dietary treatments in a 2-phase feeding program (d 0 to 14 and d 14 to 42). 
Dietary treatments were arranged in a 2 × 3 factorial, with or without antibiotic (0 
or 55 ppm, Carbadox, Phibro Pro, Teaneck, NJ) and 4 concentrations of gluco-oligo-
saccharide (0, 200, 400, and 600 ppm). Gluco-oligosaccharide product used in rooms 
1 and 2 originated from a different batch than that used in room 3. For the overall 
feeding period, no room × antibiotic × gluco-oligosaccharide or antibiotic × gluco-
oligosaccharide interactions were observed for any growth responses, but tendencies 
were found (P < 0.10) for room × gluco-oligosaccharide interaction for final BW and 
ADG. In rooms 1 and 2, antibiotic treatment increased ADG and ADFI in all feeding 
periods and improved F/G from d 14 to 28 and d 28 to 42. Increasing gluco-oligosac-
charide improved (linear, P < 0.05) ADG and F/G from d 0 to 14. It also increased 
(P = 0.047) ADG and tended (P = 0.087) to increase ADFI from d 14 to 28, but did 
not alter the growth responses from d 28 to 42. For the overall period (d 0 to 42), add-
ing an antibiotic to the diet increased (P < 0.01) ADG and ADFI, but did not affect 
F/G. Increasing gluco-oligosaccharide improved (linear, P < 0.01) ADG and F/G and 
tended (P = 0.063) to linearly increase ADFI. In room 3, a much smaller response was 
observed for antibiotic inclusion with only improved (P = 0.005) F/G from d 14 to 28 
and increased (P < 0.05) ADG and ADFI from d 28 to 42. Pigs fed increasing gluco-
oligosaccharide tended (linear, P < 0.10) to have reduced ADG and ADFI; however, 
the overall growth performance was not affected by antibiotic or gluco-oligosaccharide 
treatments. In conclusion, feeding gluco-oligosaccharide may improve growth perfor-
mance in nursery pigs, and this effect appears to be independent of the use of antibiotic 
and more prominent during the early nursery phase. However, due to some room × 
gluco-oligosaccharide interactions, further research is required to confirm the consis-
tency of the responses to the gluco-oligosaccharide used in this study.
1 Appreciation is expressed to Midori USA, Inc. (Cambridge, MA) for partial funding and New Horizon 
Farms (Pipestone, MN) for providing the animals, research facilities, and technical support. 
2 Department of Diagnostic Medicine/Pathobiology, College of Veterinary Medicine,  
Kansas State University.
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Introduction
Oligosaccharides are a group of carbohydrate polymers containing 3 to 10 simple sugars 
that can be fed to pigs as prebiotics. Mannan- (Davis et al., 2002;3 Rozeboom et al., 
20054), chito- (Liu et al., 20085), and fructo-oligosaccharides (Gebbink et al., 19996), 
have been shown to improve growth performance in young pigs. Possible mechanisms 
by which oligosaccharides benefit growth performance have been proposed and center 
on improving health status of the pig. For example, oligosaccharide may interact with 
intestinal mucosa and prevent pathogens, e.g., E. coli and Salmonella, from colonizing 
and proliferating at the mucosal surface (Miguel et al., 20047). Oligosaccharide may also 
enhance the immune system of pigs by increasing antibody titers, immunoglobulins, 
and macrophage activities (Davis et al., 20048). In addition, antibiotics have been widely 
fed to nursery pigs as growth promoters; however, concerns with antibiotic resistance 
have led to a ban on the use of growth promoting antibiotics that are medically impor-
tant for human use (FDA, 20159) in swine diets. Therefore, oligosaccharide products 
have been proposed as the alternatives to antibiotics in nursery pig diets. The objective 
of this study was to determine the effects of feeding a gluco-oligosaccharide with or 
without a feed grade antibiotic on growth performance of nursery pigs.
Procedures
The Kansas State University Institutional Animal Care Committee approved the pro-
tocol used in the experiment. The study was conducted at a commercial nursery research 
facility in southwest Minnesota. The barn was mechanically ventilated and temperature 
was maintained at approximately 80°F. Each pen (12.1 × 7.5 ft2) had completely slatted 
plastic floors and was equipped with a 6-hole, stainless-steel, dry self-feeder and a pan 
waterer. Pigs were allowed ad libitum access to feed and water throughout the experi-
ment. Diets were manufactured at a local feed mill (New Horizon Farms, Pipestone, 
MN). Feed additions to each individual pen were delivered and recorded by a robotic 
feeding system (FeedPro; Feedlogic Corp., Wilmar, MN).
3 Davis, M. E., C. V. Maxwell, D. C. Brown, B. Z. De Rodas, Z. B. Johnson, E. B. Kegley, D. H. Hellwig, 
and R. A. Dvorak. 2002. Effect of dietary mannan oligosaccharides and(or) pharmacological additions of 
copper sulfate on growth performance and immunocompetence of weanling and growing/finishing pigs. 
J. Anim. Sci. 80:2887–2894.
4  Rozeboom, D. W., D. T. Shaw, R. J. Tempelman, J. C. Miguel, J. E. Pettigrew and A. Connolly. 2005. 
Effect of mannan oligosaccharide and an antimicrobial product in nursery diets on performance of pigs 
reared on three different farms. J. Anim. Sci. 83:2637-2644.
5  Liu, P., X. S. Piao, S. W. Kim, L. Wang, Y. B. Shen, H. S. Lee, and S. Y. Li. 2008. Effects of chito-oligo-
saccharide supplementation on the growth performance, nutrient digestibility, intestinal morphology, 
and fecal shedding of Escherichia coli and Lactobacillus in weaning pigs. J. Anim. Sci. 86:2609-2618.
6  Gebbink, G. A. R., A. L. Sutton, B. T. Richert, J. A. Patterson, J. Nielsen, D. T. Kelly, M. W. A. Ver-
stegen, B. A. Williams, M. Bosch, M. Cobb, D. C. Kendall, S. DeCamp, and K. Bowers. 1999. Effects 
of addition of fructooligosaccharide (FOS) and sugar beet pulp to weanling pig diets on performance, 
microflora and intestinal health. Swine Day, vol. 31. Purdue University, pp. 53–59. 
7  Miguel, J. C., S. L. Rodriguez-Zas, and J. E. Pettigrew. 2004. Efficacy of a mannan oligosaccharide (Bio-
Mos®) for improving nursery pig performance. J. Swine Health Prod. 12:296–307.
8  Davis, M. E., D. C. Brown, C. V. Maxwell, Z. B. Johnson, E. B. Kegley, and R. A. Dvorak. 2004. Effect 
of phosphorylated mannans and pharmacological additions of zinc oxide on growth and immunocomet-
ence of weanling pigs. J. Anim. Sci. 82:581–587.
9  FDA. 2015. Federal register. 80: No. 106.
Kansas State University Agricultural Experiment Station and Cooperative Extension Service
3
Swine Day 2016
This experiment was replicated twice. In replicate 1, pigs (n = 2,376; initial BW = 11.9 
lb; PIC L337 × 1050) were housed in two rooms (48 pens in room 1 and 40 pens in 
room 2). Replicate 2 was conducted with the next group of pigs placed into room 1, but 
will be referred to as room 3 for ease of clarification. In room 3, pigs (n = 1,080; initial 
BW = 13.5 lb; PIC L337 × 1050) were housed in 40 pens. In each room, pens of pigs 
(27 pigs/pen) were blocked (6, 5, and 5 blocks in rooms 1, 2, and 3, respectively) by ini-
tial pen BW and allotted randomly to 1 of 8 dietary treatments. The dietary treatments 
were arranged in a 2 × 3 factorial, with or without antibiotic (0 or 55 ppm Carbadox, 
Phibro Animal Health Corp., Teaneck, NJ), and 4 levels of gluco-oligosaccharide (0, 
200, 400, and 600 ppm; Midori USA, Inc., Cambridge, MA). The basal diets used in 
the study are provided in Table 1. Antibiotic and/or gluco-oligosaccharide were added 
to the basal diets at the expense of corn. The 0 and 600 ppm gluco-oligosaccharide diets 
were manufactured and used to blend in the robotic feeding system to provide diets 
with 200 and 400 ppm gluco-oligosaccharide (Table 2). Gluco-oligosaccharide prod-
uct used in rooms 1 and 2 originated from a different batch from that of product used 
in room 3. Pigs were fed in 2 phases from d 0 to 14 and d 14 to 42. Pens were weighed 
and feed disappearance was measured every 7 d to determine ADG, ADFI, and F/G. 
Diet samples were taken from six feeders per dietary treatment, delivered to Kansas 
State University Swine Laboratory, and stored at -20°C. Diet samples were submitted 
to Ward Laboratories, Inc. (Kearney, NE) for analysis of DM, CP, crude fat, Ca, and 
P. Diet samples were also sent to Phibro Animal Health Corp. Feed Laboratory (State 
College, PA) for the analysis of Carbadox concentrations.
Data were analyzed using the GLIMMIX procedure of SAS (SAS Institute, Inc., Cary, 
NC) with pen as the experimental unit. The statistical model included fixed effects of 
room, antibiotic, gluco-oligosaccharide, and their interactions, with block as a random 
effect. The statistical model was simplified by removing the room × antibiotic × gluco-
oligosaccharide interaction (P > 0.10), and the degrees of freedom of non-significant 
interactions were pooled to test the remaining fixed effects. Linear and quadratic 
contrasts were conducted among the gluco-oligosaccharide concentrations and a single 
degree of freedom contrast was used to compare the treatments with and without anti-
biotic. Results were considered significant at P < 0.05 and a tendency at  
0.05 < P < 0.10.
Results and Discussion
Analyzed chemical composition of dietary treatments generally matched formulated 
nutrient levels. Analyzed CP and antibiotic concentrations were slightly lower than the 
formulated levels, but were consistent across treatments, phases, and rooms.
The P values for the fixed effects on ADG, ADFI, F/G, and BW are shown in Table 3. 
No room × antibiotic × gluco-oligosaccharide interactions were significant (P > 0.10) 
for any of the growth responses and, therefore, were removed from the statistical model. 
Tendencies for room × gluco-oligosaccharide interactions were observed for final BW 
(P = 0.059; Figure 1) and overall ADG (P = 0.087; Figure 2). Pigs from rooms 1 and 2 
had similar response trends to the gluco-oligosaccharide but shared different patterns 
than that of pigs in room 3 (Figure 1 and 2). Pigs from the first (room 1 and 2) and 
second (room 3) replicates of the experiment were from different batches, raised in dif-
ferent time points, and fed a different batch of the gluco-oligosaccharide, which might 
Kansas State University Agricultural Experiment Station and Cooperative Extension Service
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explain the discrepancy in pig performance between experimental replicates. Therefore, 
data from room 1 and 2 were pooled to test the treatment effects of gluco-oligosaccha-
ride and antibiotic separately from room 3.
No interactive effects among room, antibiotic, and gluco-oligosaccharide were observed 
for removal rate (P > 0.42). Percentage of pigs removed from the experiment was not 
affected by the antibiotic or gluco-oligosaccharide treatments, but tended (P = 0.064) 
to vary among rooms. Removal rate in room 3 (4.2%) was greater (P < 0.05) than in 
room 2 (1.9%), but was not statistically different from that in room 1 (2.8%); no differ-
ences were observed between removal rates in room 1 and 2.
No antibiotic × gluco-oligosaccharide interactions were observed in the analyses of 
growth responses. In a review of 29 studies, Miguel et al. (20047) concluded that the 
effects of feeding mannan-oligosaccharide on growth performance of nursery pigs were 
independent to the application of an antibiotic in the diet, and the effects are addi-
tive. Growth performance of pigs fed in rooms 1 and 2 is presented in Table 4. Body 
weight of pigs fed antibiotic was greater (P = 0.073) at d 14 and (P < 0.01) at d 28 and 
42. Feeding an antibiotic improved (P = 0.026) ADG, tended to increase (P = 0.067) 
ADFI, but did not affect F/G of pigs from d 0 to 14. Pigs fed diets containing antibiotic 
had improved (P < 0.05) ADG, ADFI, and F/G compared with those fed diets with-
out antibiotic from d 14 to 28 and 28 to 42. For the overall feeding period (d 0 to 42), 
ADG and ADFI were improved (P < 0.01), but F/G was unaffected by addition of a 
dietary antibiotic. 
In rooms 1 and 2, increasing gluco-oligosaccaride increased (linear, P < 0.01) BW on 
d 14, 28, and 42. Increasing gluco-oligosaccharide improved (linear, P < 0.01) ADG 
and F/G, but did not affect ADFI from d 0 to 14. From d 14 to 28, increasing gluco-
oligosaccharide increased (linear, P = 0.047) ADG and tended to increase (linear, 
P = 0.087) ADFI, but had no effect on F/G. Growth performance of pigs from d 28 to 
42 were not affected by added gluco-oligosaccharide. For the overall period (d 0 to 42), 
increasing gluco-oligosaccharide improved (linear, P < 0.01) ADG and F/G and tended 
to increase (linear, P = 0.063) ADFI. Improved pig growth performance during nursery 
phases has been reported in other studies (Davis et al., 2002;3 Rozeboom et al., 2005;4 
Liu et al., 20085) when mannan- or chito-oligosaccharides were added in the diets. 
Miguel et al. (20047) suggested that pigs in the first 1 to 2 weeks post-weaning with rela-
tively slow growth rate had more prominent response to oligosaccharide products than 
older nursery pigs, which supported our findings that gluco-oligosaccharide treatment 
promoted ADG and F/G during d 0 to 14 and increased ADG and ADFI from d 14 to 
28 but did not affect growth responses from d 28 to 42.
Growth performance of pigs in room 3 is presented in Table 5. Neither the antibiotic 
nor gluco-oligosaccharide treatments affected the BW of pigs. In contrast to the ob-
servations in rooms 1 and 2, a much smaller response was observed for dietary anti-
biotic addition in room 3, with the only improved (P = 0.005) F/G from d 14 to 28 
and increased (P < 0.05) ADG and ADFI from d 28 to 42. No response was observed 
for added gluco-oligosaccharide, except that pigs tended (linear, P < 0.10) to have 
decreased ADG and ADFI from d 14 to 28 with increasing gluco-oligosaccharides. 
Discrepancies in pigs’ responses to gluco-oligosaccharide treatment between experimen-
Kansas State University Agricultural Experiment Station and Cooperative Extension Service
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tal replicates might be attributed to the environment, health status of pigs, quality of 
dietary ingredients, as well as many other factors (Miguel et al., 20047). Rozeboom et al. 
(20054) also reported inconsistent responses of pigs to dietary mannan-oligosaccharide 
in an experiment where improved ADG, ADFI, and F/G were observed in one research 
farm, but these responses were not able to be replicated in another two farms during the 
same feeding period; likewise, antibiotics were reported to enhance pig growth perfor-
mance in two out of the three farms, but no effect was observed in the third farm.
In summary, these results suggest that the gluco-oligosaccharide used in these studies 
may improve growth performance of nursery pigs, especially during the early post-
weaning period, and the magnitude of these effects may be related to the concentration 
of gluco-oligosaccharide and independent to the use of antibiotic in the diets. However, 
further research is required to confirm the consistency of pigs’ responses to antibiotic 
and gluco-oligosaccharide treatments. 
Kansas State University Agricultural Experiment Station and Cooperative Extension Service
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Table 1. Composition of base diets (as-fed basis)
Items Phase 11 Phase 21
Ingredients, %
  Corn 50.53 56.85
  Soybean meal (48% CP) 25.35 29.81
  Corn DDGS, 6-9% oil 7.50 10.00
  Fish meal 3.75 0.00
  Dried whey 10.00 0.00
  Calcium carbonate 0.90 1.15
  Monocalcium phosphate (22% P) 0.35 0.80
  Sodium chloride 0.35 0.35
  L-Lys HCl 0.40 0.45
  DL-Met 0.15 0.13
  L-Thr 0.16 0.15
  L-Trp 0.03 0.02
  Phytase2 0.03 0.03
  Zinc oxide 0.26 0.00
  Tri-basic copper chloride 0.03 0.03
  Trace mineral premix 0.13 0.13
  Vitamin premix 0.10 0.10
  Antibiotic3 --- ---
  Gluco-oligosaccharide premix4 --- ---
Total 100.00 100.00
continued
Kansas State University Agricultural Experiment Station and Cooperative Extension Service
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Table 1. Composition of base diets (as-fed basis)
Items Phase 11 Phase 21
Calculated analysis
Standardized ileal digestible (SID) AA, %
    Lys 1.35 1.30
    Ile:Lys 59 60
    Leu:Lys 125 131
    Met:Lys 36 34
    Met and Cys:Lys 57 56
    Thr:Lys 64 63
    Trp:Lys 18 19
    Val:Lys 65 66
Total Lys, % 1.52 1.47
CP, % 22.44 22.28
ME, kcal/lb 1,502 1,490
NE, kcal/lb 1,015 966
SID Lys:ME, g/Mcal 4.08 3.96
Ca, % 0.73 0.70
P, % 0.61 0.59
Available P, % 0.47 0.42
1 Phase 1 diets were fed from d 0 to 14, and Phase 2 diets were fed from d 14 to 42.
2 Optiphos 2000 (Enzyvia, Sheridan, IN).
3 Carbadox (Mecadox, Phibro Animal Health Corp., Teaneck, NJ); product was added to the base diets at 55 ppm 
to form antibiotic treatments.



















Table 2. Analyzed composition of experimental diets (as-fed basis)1
Phase 12 Phase 22
Antibiotic,3 ppm: 0 0 0 0 55 55 55 55 0 0 0 0 55 55 55 55
Gluco-oligosaccharide,4 ppm: 0 200 400 600 0 200 400 600 0 200 400 600 0 200 400 600
Room 1 and 2
  DM, % 89.4 89.0 89.8 89.4 89.0 89.1 89.6 89.4 88.7 88.9 88.3 88.2 89.0 88.4 88.9 88.5
  CP, % 20.2 20.5 21.2 21.4 20.3 21.1 20.7 21.7 19.8 21.0 18.8 19.2 19.7 20.5 20.6 21.4
  Fat, % 3.0 2.8 2.8 2.8 2.8 2.7 2.7 2.8 3.3 3.0 2.9 2.9 2.8 2.9 3.1 2.9
  Ca, % 0.70 0.81 0.84 0.77 0.90 1.00 1.00 1.02 0.81 0.72 0.65 0.77 0.99 0.88 0.83 0.96
  P, % 0.61 0.62 0.60 0.62 0.58 0.63 0.64 0.68 0.59 0.60 0.58 0.62 0.61 0.64 0.63 0.63
  Carbadox,5 ppm < 1 --- --- < 1 47.0 --- --- 45.0 < 1 --- --- 1.5 50.0 --- --- 41.0
Room 3
  DM, % 89.1 88.4 88.9 88.9 88.5 88.4 88.4 90.1 87.5 87.0 86.9 86.9 87.4 86.9 87.2 86.9
  CP, % 20.2 20.7 21.5 21.7 21.2 21.4 21.6 22.2 21.9 19.5 21.6 21.3 20.4 21.1 21.9 21.7
  Fat, % 3.1 3.1 3.0 2.9 2.9 3.0 2.8 2.9 2.9 2.7 2.8 2.7 2.5 2.6 2.6 3.2
  Ca, % 0.77 0.84 0.80 0.79 0.91 0.94 1.05 0.95 0.74 0.75 0.76 0.80 1.16 1.06 0.97 0.85
  P, % 0.57 0.60 0.61 0.63 0.62 0.65 0.64 0.64 0.57 0.60 0.63 0.60 0.59 0.62 0.60 0.60
  Carbadox,5 ppm < 1 --- --- < 1 41.0 --- --- 51.0 < 1 --- --- < 1 42.0 --- --- 45.0
1 Multiple samples of each diet were collected, blended and subsampled, and analyzed (Ward Laboratories, Inc., Kearney, NE).
2 Phase 1 diets were fed from d 0 to 14, and Phase 2 diets were fed from d 14 to 42.
3 Carbadox (Mecadox, Phibro Animal Health Corp., Teaneck, NJ).
4 Gluco-oligosaccharide (Midori USA, Inc., Cambridge, MA).
5 The diets with lowest and highest oligosaccharide content were tested for Carbadox as they were blended for the intermediate treatments.
Kansas State University Agricultural Experiment Station and Cooperative Extension Service
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Table 3. P values for the sources of variation in the analyses of growth performance1
Source of variation d 0 to 14 d 14 to 28 d 28 to 42 d 0 to 42
BW2,3
  Antibiotic4 0.472 <0.001 <0.001 ---
  Gluco-oligosaccharide5 0.008 0.150 0.195 ---
  Room <0.001 0.030 0.188 ---
  Antibiotic × gluco-oligosaccharide 0.410 0.505 0.603 ---
  Room × antibiotic 0.143 0.063 0.220 ---
  Room × gluco-oligosaccharide 0.772 0.168 0.059 ---
ADG3
  Antibiotic 0.294 <0.001 <0.001 <0.001
  Gluco-oligosaccharide 0.006 0.897 0.842 0.304
  Room <0.001 <0.001 0.093 0.002
  Antibiotic × gluco-oligosaccharide 0.612 0.417 0.139 0.446
  Room × antibiotic 0.083 0.143 0.947 0.243
  Room × gluco-oligosaccharide 0.803 0.162 0.033 0.087
ADFI3
  Antibiotic 0.308 0.044 <0.001 <0.001
  Gluco-oligosaccharide 0.397 0.761 0.591 0.559
  Room 0.001 <0.001 0.235 0.065
  Antibiotic × gluco-oligosaccharide 0.433 0.523 0.327 0.524
  Room × antibiotic 0.244 0.139 0.490 0.201
  Room × gluco-oligosaccharide 0.993 0.234 0.188 0.409
F/G3
  Antibiotic 0.958 <0.001 0.078 0.054
  Gluco-oligosaccharide 0.007 0.724 0.883 0.070
  Room <0.001 0.026 0.666 0.033
  Antibiotic × gluco-oligosaccharide 0.937 0.202 0.521 0.486
  Room × antibiotic 0.234 0.997 0.085 0.609
  Room × gluco-oligosaccharide 0.534 0.744 0.338 0.259
1 A total of 3,456 pigs (PIC L337 × 1050, initially 12.4 lb BW) were used in a 42-d study. Pigs were housed in 3 commercial 
research rooms with 27 pigs per pen and a total of 16 pens per treatment.
2 Body weight of pigs was recorded at the end of a feeding period.
3 Effects of room × antibiotic × oligosaccharide interaction were not significant (P > 0.40) for  
        the overall trial (d 0 to 42) and therefore, were removed from the statistical model.
4 Carbadox (Mecadox, Phibro Animal Health Corp., Teaneck, NJ).


















Table 4. Effects of antibiotic and increasing gluco-oligosaccharide on growth performance of pigs (Rooms 1 and 2)1
Probability, P <
Antibiotic,2 ppm Gluco-oligosaccharide,3 ppm Gluco-oligosaccharide 
Item 0 55 SEM 0 200 400 600 SEM Antibiotic Linear Quadratic
Removal, % 2.54 2.16 0.005 3.03 1.32 2.73 2.75 0.008 0.564 0.704 0.161
BW, lb
  d 0 11.9 11.9 0.12 11.8 11.9 11.9 12.0 0.13 0.596 0.115 0.712
  d 14 21.1 21.3 0.23 20.8 21.1 21.4 21.5 0.25 0.073 0.001 0.758
  d 28 35.0 36.3 0.41 35.0 35.5 35.9 36.2 0.45 <0.001 0.001 0.532
  d 42 52.1 54.0 0.46 52.1 52.9 53.2 53.9 0.54 <0.001 0.002 0.985
d 0 to 14
  ADG, lb 0.58 0.60 0.008 0.56 0.58 0.59 0.61 0.010 0.026 0.000 0.901
  ADFI, lb 0.79 0.81 0.010 0.79 0.80 0.81 0.80 0.012 0.067 0.224 0.475
  F/G 1.37 1.36 0.019 1.41 1.38 1.36 1.32 0.022 0.305 <0.001 0.652
d 14 to 28
  ADG, lb 0.99 1.06 0.015 1.00 1.03 1.03 1.04 0.018 <0.001 0.047 0.403
  ADFI, lb 1.41 1.45 0.019 1.40 1.43 1.45 1.44 0.022 0.010 0.087 0.317
  F/G 1.42 1.38 0.007 1.40 1.39 1.40 1.39 0.010 <0.001 0.502 0.911
d 28 to 42
  ADG, lb 1.20 1.26 0.012 1.21 1.24 1.22 1.24 0.016 0.001 0.230 0.958
  ADFI, lb 1.86 1.97 0.016 1.90 1.91 1.92 1.94 0.022 <0.001 0.146 0.785
  F/G 1.55 1.57 0.016 1.56 1.55 1.57 1.56 0.018 0.020 0.712 0.710
d 0 to 42
  ADG, lb 0.92 0.97 0.008 0.92 0.95 0.95 0.96 0.010 <0.001 0.004 0.610
  ADFI, lb 1.35 1.41 0.013 1.36 1.38 1.39 1.39 0.016 <0.001 0.063 0.550
  F/G 1.46 1.46 0.008 1.47 1.46 1.46 1.45 0.009 0.136 0.007 0.998
1 A total of 2,376 pigs (PIC L337 × 1050, initially 11.9 lb BW) were housed in rooms 1 and 2 and used in a 42-d study. Room 1 contained 48 pens with 6 pens per treatment and room 2 contained 40 
pens with 5 pens per treatment.
2 Carbadox (Mecadox, Phibro Animal Health Corp., Teaneck, NJ).


















Table 5. Effects of antibiotic and increasing gluco-oligosaccharide on growth performance of pigs (Room 3)1
Probability, P <
Antibiotic,2 ppm Gluco-oligosaccharide,3 ppm Gluco-oligosaccharide 
Item 0 55 SEM 0 200 400 600 SEM Antibiotic Linear Quadratic
Removal, % 4.09 4.22 0.011 3.05 5.49 4.64 3.84 0.016 0.924 0.729 0.231
BW, lb
  d 0 13.5 13.5 0.18 13.4 13.4 13.5 13.6 0.19 0.561 0.079 0.541
  d 14 23.2 22.9 0.34 22.8 23.1 23.2 23.1 0.37 0.237 0.333 0.399
  d 28 34.4 34.6 0.61 34.6 34.7 34.5 34.1 0.67 0.691 0.370 0.604
  d 42 53.4 54.1 0.68 54.1 53.5 54.5 53.0 0.81 0.299 0.389 0.414
d 0 to 14
  ADG, lb 0.54 0.53 0.012 0.53 0.53 0.54 0.54 0.016 0.224 0.427 0.941
  ADFI, lb 0.85 0.84 0.015 0.83 0.85 0.84 0.85 0.018 0.461 0.450 0.549
  F/G 1.57 1.60 0.028 1.58 1.60 1.59 1.57 0.033 0.208 0.701 0.498
d 14 to 28
  ADG, lb 0.86 0.89 0.023 0.90 0.87 0.87 0.85 0.027 0.250 0.070 0.856
  ADFI, lb 1.21 1.20 0.028 1.24 1.21 1.21 1.17 0.034 0.920 0.073 0.777
  F/G 1.40 1.36 0.011 1.37 1.39 1.39 1.38 0.015 0.005 0.856 0.322
d 28 to 42
  ADG, lb 1.23 1.27 0.018 1.27 1.22 1.29 1.22 0.024 0.029 0.505 0.707
  ADFI, lb 1.89 1.96 0.025 1.95 1.89 1.98 1.88 0.034 0.035 0.495 0.509
  F/G 1.54 1.54 0.024 1.54 1.55 1.54 1.54 0.026 0.865 0.926 0.530
d 0 to 42
  ADG, lb 0.88 0.90 0.012 0.90 0.88 0.90 0.88 0.016 0.214 0.396 0.997
  ADFI, lb 1.33 1.35 0.020 1.35 1.32 1.36 1.31 0.024 0.350 0.391 0.615
  F/G 1.50 1.49 0.011 1.49 1.50 1.50 1.49 0.013 0.215 0.917 0.127
1 A total of 1,080 pigs (PIC L337 × 1050, initially 13.5 lb BW) were housed in rooms 3 and used in a 42-d study. Room 3 contained 40 pens with 5 pens per treatment.
2 Carbadox (Mecadox, Phibro Pro, Teaneck, NJ).
3 Midori USA, Inc. (Cambridge, MA).

































0 200 400 600
Room 2
0 200 400 600
Room 3


































0 200 400 600
Room 2
0 200 400 600
Room 3
Figure 2. Effects of room × gluco-oligosaccharide interaction on overall ADG (P = 0.087).
